Salveen Richter
Stock Analyst at Goldman Sachs
(2.39)
# 2,393
Out of 4,843 analysts
209
Total ratings
42.02%
Success rate
-0.81%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $51 → $44 | $3.73 | +1,081.21% | 4 | May 9, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Neutral | $53 → $47 | $36.78 | +27.79% | 4 | May 8, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $15 → $13 | $9.51 | +36.70% | 3 | May 8, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Buy | $178 → $100 | $38.61 | +159.00% | 4 | May 7, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $124 → $104 | $58.55 | +77.63% | 1 | May 5, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $37 → $41 | $26.21 | +56.43% | 2 | May 2, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Neutral | $12 → $9 | $6.21 | +44.93% | 2 | May 2, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $9 → $10 | $9.31 | +7.41% | 11 | May 2, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $917 → $804 | $605.39 | +32.81% | 11 | Apr 30, 2025 | |
| BIIB Biogen | Maintains: Buy | $219 → $197 | $132.75 | +48.40% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $36 → $32 | $17.41 | +83.80% | 8 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $3.08 | +484.42% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $96 | $111.11 | -13.60% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $99 → $51 | $26.93 | +89.38% | 10 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $13.54 | +195.42% | 5 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $12 | $7.45 | +61.07% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $20 | $14.90 | +34.23% | 7 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $66.04 | +6.00% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $198 → $370 | $292.90 | +26.32% | 5 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $67 → $76 | $35.04 | +116.89% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $33 → $37 | $33.46 | +10.58% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $19 → $11 | $6.52 | +68.71% | 11 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $53 | $31.84 | +66.46% | 9 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $283.54 | +23.44% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $447.09 | +25.03% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $13.06 | -61.72% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $1.18 | +2,527.12% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $297.00 | -24.24% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $1.26 | +1,646.03% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.40 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $4.92 | +509.76% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $14 | $0.67 | +1,980.24% | 3 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $4.45 | +102.25% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $2.75 | +9.09% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $15 → $12 | $22.29 | -46.16% | 8 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $2.27 | +164.32% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $51.91 | -17.16% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $40 → $60 | $4.97 | +1,107.24% | 6 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $1.44 | +38.89% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $7.80 | +1,182.05% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $30 | $0.45 | +6,541.58% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $94.29 | -46.97% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $16.82 | +167.54% | 1 | Mar 17, 2020 |
4D Molecular Therapeutics
May 9, 2025
Maintains: Buy
Price Target: $51 → $44
Current: $3.73
Upside: +1,081.21%
CRISPR Therapeutics AG
May 8, 2025
Maintains: Neutral
Price Target: $53 → $47
Current: $36.78
Upside: +27.79%
Arcus Biosciences
May 8, 2025
Maintains: Neutral
Price Target: $15 → $13
Current: $9.51
Upside: +36.70%
Sarepta Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $178 → $100
Current: $38.61
Upside: +159.00%
BioMarin Pharmaceutical
May 5, 2025
Maintains: Buy
Price Target: $124 → $104
Current: $58.55
Upside: +77.63%
Summit Therapeutics
May 2, 2025
Maintains: Buy
Price Target: $37 → $41
Current: $26.21
Upside: +56.43%
Amicus Therapeutics
May 2, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $6.21
Upside: +44.93%
Adaptive Biotechnologies
May 2, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $9.31
Upside: +7.41%
Regeneron Pharmaceuticals
Apr 30, 2025
Maintains: Buy
Price Target: $917 → $804
Current: $605.39
Upside: +32.81%
Biogen
Apr 23, 2025
Maintains: Buy
Price Target: $219 → $197
Current: $132.75
Upside: +48.40%
Mar 3, 2025
Maintains: Neutral
Price Target: $36 → $32
Current: $17.41
Upside: +83.80%
Feb 27, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $3.08
Upside: +484.42%
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $111.11
Upside: -13.60%
Jan 29, 2025
Downgrades: Neutral
Price Target: $99 → $51
Current: $26.93
Upside: +89.38%
Jan 28, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $13.54
Upside: +195.42%
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $7.45
Upside: +61.07%
Dec 12, 2024
Maintains: Neutral
Price Target: $9 → $20
Current: $14.90
Upside: +34.23%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $66.04
Upside: +6.00%
Aug 16, 2024
Upgrades: Buy
Price Target: $198 → $370
Current: $292.90
Upside: +26.32%
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $35.04
Upside: +116.89%
Aug 2, 2024
Maintains: Sell
Price Target: $33 → $37
Current: $33.46
Upside: +10.58%
Jul 26, 2024
Maintains: Neutral
Price Target: $19 → $11
Current: $6.52
Upside: +68.71%
Jun 4, 2024
Maintains: Neutral
Price Target: $33 → $53
Current: $31.84
Upside: +66.46%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $283.54
Upside: +23.44%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $447.09
Upside: +25.03%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $13.06
Upside: -61.72%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $1.18
Upside: +2,527.12%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $297.00
Upside: -24.24%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $1.26
Upside: +1,646.03%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.40
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $4.92
Upside: +509.76%
Nov 10, 2022
Maintains: Buy
Price Target: $25 → $14
Current: $0.67
Upside: +1,980.24%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $4.45
Upside: +102.25%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $2.75
Upside: +9.09%
Nov 4, 2022
Downgrades: Sell
Price Target: $15 → $12
Current: $22.29
Upside: -46.16%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $2.27
Upside: +164.32%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $51.91
Upside: -17.16%
Aug 19, 2022
Maintains: Sell
Price Target: $40 → $60
Current: $4.97
Upside: +1,107.24%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $1.44
Upside: +38.89%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $7.80
Upside: +1,182.05%
Mar 4, 2021
Upgrades: Buy
Price Target: $28 → $30
Current: $0.45
Upside: +6,541.58%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $94.29
Upside: -46.97%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $16.82
Upside: +167.54%